AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Marinomed Biotech AG

Director's Dealing Apr 21, 2023

749_dirs_2023-04-21_5ffe68db-89d3-41d4-99dd-bf50fc6a3b0b.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

News-Service of the pressetext news agency Josefstädter Straße 44, 1080 Vienna, Austria, phone: +43 1 81140-0

Publication: 21.04.2023 10:45 Source: https://www.pressetext.com/news/20230421021 Keywords: Directors' Dealings / Eigengeschäfte von Führungskräften / Marinomed Biotech AG

Managers' transactions announcement according to article 19 MAR

Marinomed Biotech AG: Managers' transactions announcement according to article 19 MAR

Korneuburg (pta/21.04.2023/10:45) - Announcement

1
Details of the person discharging managerial responsibilities/person closely associated
a) Name Brigitte Ederer
2
Reason for the notification
a) Position/status Member of the Supervisory Board
b) Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction
monitor
a) Name Marinomed Biotech AG
b) LEI 529900GN3B1EN80XF405
4
Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
b) Nature of the transaction Purchase
c) Price(s) Volume(s)
37.562667 150
d) Aggregated price Aggregated volume
37.562667 5,634.4
e) Date of the transaction 20.04.2023 UTC+2
f) Place of the transaction Vienna Stock Exchange
MIC XWBO
Emitter: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Contact Person: Pascal Schmidt, CFO
Phone: +43 2262 90300
E-Mail: [email protected]
Website: www.marinomed.com
ISIN(s): ATMARINOMED6 (Share)
Stock Exchange(s): Official Trade in Vienna

News transmitted by pressetext. The emitter is responsible for the content.

Talk to a Data Expert

Have a question? We'll get back to you promptly.